ClinicalTrials.gov
public full text
Public Domain
Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mineralocorticoid Receptor Antagonists in End Stage Renal Disease#1139691
- Effect of the Aquaretic Tolvaptan on Nitric Oxide System#1140164
- Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke#876740
- Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA)#916092
- Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome#245435
Record · ID 127722
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive